SCHEMBL5162953

SCHEMBL5162953

CCCC(Oc1cccc(-c2noc(C)n2)c1)C(=O)Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
KIFC1 Q9BW19 8/20 0.43
RAB9A P51151 3/20 0.43
TP53 P04637 3/20 0.43
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
SPHK2 Q9NRA0 1/20 0.42
SPHK1 Q9NYA1 1/20 0.42
MAPT P10636 3/20 0.42
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165451 0.90 PPARG (0.52) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL5165350 0.89 L3MBTL1 (0.50) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL14539769 0.86 L3MBTL1 (0.49) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL14408258 0.84 L3MBTL1 (0.45) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL7183487 0.83 L3MBTL1 (0.48) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL14408266 0.82 L3MBTL1 (0.52) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL14539768 0.82 L3MBTL1 (0.52) L3MBTL1KIFC1RAB9ATP53NPC1
SCHEMBL5163666 0.76 MAPK14 (0.47) RAB9ANPC1SMN1; SMN2LMNAMAPT
SCHEMBL16481854 0.76 L3MBTL1 (0.64) L3MBTL1RAB9ATP53NPC1SMN1; SMN2
SCHEMBL1020649 0.75 L3MBTL1 (0.68) L3MBTL1KIFC1RAB9ATP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed
EP-1351938-A1 PHENYL DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-15 EP disclosed
WO-2002057236-A1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 L3MBTL1 389/4885KIFC1 4604/4885RAB9A 2014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.